OncLive® On Air: Observing the Latest Developments in Ovarian Cancer in NYC on Apple Podcasts
St. Jude Research on Twitter: "Dr. Thomas E. Merchant discusses the incidence of the brain tumor craniopharyngioma. Watch on @OncLive. https://t.co/2mr8ritRMg #RareDiseaseDay https://t.co/v8E5c8C4Jj" / Twitter
OncLiveTV - YouTube
The Angeles Clinic and Research Institute - Omid Hamid, MD, chief, translational research and immunotherapy, discusses using immune therapy to treat patients with melanoma. http://www.onclive.com/onclive-tv/dr-hamid-on-immune-therapy-in-melanoma | Facebook
Weill Cornell Genitourinary Cancer Program - One-minute rundown: In this OncLive video, Dr. Scott Tagawa discusses the benefits of radium-223 dichloride (Xofigo) in prostate cancer. https://bit.ly/3BB1W98 | Facebook
Dr. Grothey on the Potential Utility of TAS-102/Bevacizumab in Metastatic CRC - West Cancer Center
OncLive TV | Page 526
Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma | UAMS Health
OncLive Video: Enrollment disparities in pivotal clinical trials - University of Illinois Cancer Center
Dr. Vaena on the Importance of Risk Stratification in Prostate Cancer - West Cancer Center
OncLiveTV - YouTube
Dr. Pierluigi Porcu, MD – Philadelphia, PA | Oncology
OncLive - Clinical Oncology News, Cancer Expert Insights
Leah Buletti » Cancer Center » UF Health Cancer Center » University of Florida
OncLiveTV - YouTube
University of Illinois Cancer Center Strategic Alliance Partnership: OncLive - University of Illinois Cancer Center
Cancer Center » UF Health Cancer Center » University of Florida
OncLive TV series on neuroendocrine tumors Archives - Carcinoid Cancer Foundation
OncLive TV Releases 2 More Videos in Neuroendocrine Tumors Series - Carcinoid Cancer Foundation
OncLive® On Air on Apple Podcasts
Neeraj Agarwal, MD, FASCO on Twitter: "Mitomycin gel receives FDA approval today as the 1st drug therapy for low grade upper tract urothelial carcinoma: Based on 58% CR noted in the OLYMPUS
